• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪细胞促进乳腺癌细胞扩散的早期步骤 白细胞介素-8。

Adipocytes Promote Early Steps of Breast Cancer Cell Dissemination Interleukin-8.

机构信息

Department of Oncology, Linköping University, Linköping, Sweden.

Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.

出版信息

Front Immunol. 2018 Jul 30;9:1767. doi: 10.3389/fimmu.2018.01767. eCollection 2018.

DOI:10.3389/fimmu.2018.01767
PMID:30105032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6077262/
Abstract

Fat is a major tissue component in human breast cancer (BC). Whether breast adipocytes (BAd) affect early stages of BC metastasis is yet unknown. BC progression is dependent on angiogenesis and inflammation, and interleukin-8 (IL-8) and vascular endothelial growth factor (VEGF) are key regulators of these events. Here, we show that BAd increased the dissemination of estrogen receptor positive BC cells (BCC) in the zebrafish model of metastasis, while dissemination of the more aggressive and metastatic BCC such as estrogen receptor negative was unaffected. While anti-VEGF and anti-IL-8 exhibited equal inhibition of angiogenesis at the primary tumor site, anti-IL-8 reduced BCC dissemination whereas anti-VEGF had minor effects on this early metastatic event. Mechanistically, overexpression of cell-adhesion molecules in BCC and neutrophils IL-8 increased the dissemination of BCC. Importantly, the extracellular levels of IL-8 were 40-fold higher than those of VEGF in human BC. Our results suggest that IL-8 is a clinical relevant and promising therapeutic target for human BC.

摘要

脂肪是人类乳腺癌(BC)的主要组织成分。乳腺脂肪细胞(BAd)是否会影响 BC 转移的早期阶段尚不清楚。BC 的进展依赖于血管生成和炎症,白细胞介素-8(IL-8)和血管内皮生长因子(VEGF)是这些事件的关键调节剂。在这里,我们表明,BAd 增加了雌激素受体阳性 BC 细胞(BCC)在转移的斑马鱼模型中的扩散,而雌激素受体阴性的侵袭性和转移性 BCC 的扩散则不受影响。虽然抗 VEGF 和抗 IL-8 在原发性肿瘤部位均能同等抑制血管生成,但抗 IL-8 减少了 BCC 的扩散,而抗 VEGF 对这一早期转移事件的影响较小。从机制上讲,BCC 和中性粒细胞中细胞黏附分子的过表达增加了 BCC 的扩散。重要的是,人 BC 中 IL-8 的细胞外水平比 VEGF 高 40 倍。我们的研究结果表明,IL-8 是治疗人类 BC 的一个有临床意义和有前途的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d57/6077262/54d9f0304867/fimmu-09-01767-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d57/6077262/9463ede5ff45/fimmu-09-01767-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d57/6077262/3921406abd0e/fimmu-09-01767-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d57/6077262/ef100fafc3e9/fimmu-09-01767-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d57/6077262/1d65f61fec96/fimmu-09-01767-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d57/6077262/7ab228f302e5/fimmu-09-01767-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d57/6077262/1dca59a34db0/fimmu-09-01767-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d57/6077262/54d9f0304867/fimmu-09-01767-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d57/6077262/9463ede5ff45/fimmu-09-01767-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d57/6077262/3921406abd0e/fimmu-09-01767-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d57/6077262/ef100fafc3e9/fimmu-09-01767-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d57/6077262/1d65f61fec96/fimmu-09-01767-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d57/6077262/7ab228f302e5/fimmu-09-01767-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d57/6077262/1dca59a34db0/fimmu-09-01767-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d57/6077262/54d9f0304867/fimmu-09-01767-g007.jpg

相似文献

1
Adipocytes Promote Early Steps of Breast Cancer Cell Dissemination Interleukin-8.脂肪细胞促进乳腺癌细胞扩散的早期步骤 白细胞介素-8。
Front Immunol. 2018 Jul 30;9:1767. doi: 10.3389/fimmu.2018.01767. eCollection 2018.
2
Estradiol Promotes Breast Cancer Cell Migration via Recruitment and Activation of Neutrophils.雌二醇通过招募和激活中性粒细胞促进乳腺癌细胞迁移。
Cancer Immunol Res. 2017 Mar;5(3):234-247. doi: 10.1158/2326-6066.CIR-16-0150. Epub 2017 Feb 3.
3
Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.在小鼠模型中,抗血管内皮生长因子(VEGF)和抗表皮生长因子受体(EGFR)的联合应用主要通过抑制AKT和ERK信号通路来减弱结直肠癌的生长和血管生成。
BMC Cancer. 2016 Oct 12;16(1):791. doi: 10.1186/s12885-016-2834-8.
4
Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo.他莫昔芬在体内可抑制乳腺癌中血管内皮生长因子的分泌。
Cancer Res. 2003 Dec 15;63(24):8742-8.
5
Mammary adipocytes promote breast tumor cell invasion and angiogenesis in the context of menopause and obesity.绝经和肥胖背景下,乳腺脂肪细胞促进乳腺癌细胞浸润和血管生成。
Biochim Biophys Acta Mol Basis Dis. 2024 Oct;1870(7):167325. doi: 10.1016/j.bbadis.2024.167325. Epub 2024 Jun 24.
6
Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.Nef-M1,一种CXCR4的肽拮抗剂,可抑制结肠癌和乳腺癌中的肿瘤血管生成以及上皮-间质转化。
Oncotarget. 2015 Sep 29;6(29):27763-77. doi: 10.18632/oncotarget.4615.
7
Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.巨噬细胞移动抑制因子的过表达诱导人乳腺癌血管生成。
Cancer Lett. 2008 Mar 18;261(2):147-57. doi: 10.1016/j.canlet.2007.11.028. Epub 2008 Jan 2.
8
Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis.葫芦素B通过VEGF介导的FAK/MMP-9信号轴抑制来抑制乳腺癌转移和血管生成。
Int J Biochem Cell Biol. 2016 Aug;77(Pt A):41-56. doi: 10.1016/j.biocel.2016.05.014. Epub 2016 May 19.
9
Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2.肥胖通过上调 IL-6 并可能上调 FGF-2 来促进乳腺癌对抗 VEGF 治疗的耐药性。
Sci Transl Med. 2018 Mar 14;10(432). doi: 10.1126/scitranslmed.aag0945.
10
Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.PJ-8,一种新型血管内皮生长因子受体信号抑制剂的抗血管生成机制。
Carcinogenesis. 2012 May;33(5):1022-30. doi: 10.1093/carcin/bgs127. Epub 2012 Mar 20.

引用本文的文献

1
BMI-dependent prognostic role of EEF1G in breast cancer: A 15-year follow-up of the Guangzhou Breast Cancer Cohort Study.EEF1G在乳腺癌中依赖BMI的预后作用:广州乳腺癌队列研究的15年随访
Cancer Med. 2025 Sep;14(17):e70227. doi: 10.1002/cam4.70227.
2
Advancing Breast Cancer Treatment: The Role of Immunotherapy and Cancer Vaccines in Overcoming Therapeutic Challenges.推进乳腺癌治疗:免疫疗法和癌症疫苗在克服治疗挑战中的作用。
Vaccines (Basel). 2025 Mar 24;13(4):344. doi: 10.3390/vaccines13040344.
3
Angiogenesis, signaling pathways, and animal models.

本文引用的文献

1
Interleukin-8 in cancer pathogenesis, treatment and follow-up.白细胞介素-8 在癌症发病机制、治疗和随访中的作用。
Cancer Treat Rev. 2017 Nov;60:24-31. doi: 10.1016/j.ctrv.2017.08.004. Epub 2017 Aug 31.
2
Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts.在斑马鱼异种移植模型中对组合结直肠癌治疗进行单细胞功能和化学敏感性分析。
Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):E8234-E8243. doi: 10.1073/pnas.1618389114. Epub 2017 Aug 23.
3
Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients.
血管生成、信号通路与动物模型。
Chin Med J (Engl). 2025 May 20;138(10):1153-1162. doi: 10.1097/CM9.0000000000003561. Epub 2025 Apr 21.
4
Dissecting the emerging role of cancer-associated adipocyte-derived cytokines in remodeling breast cancer progression.剖析癌症相关脂肪细胞来源的细胞因子在重塑乳腺癌进展中的新作用。
Heliyon. 2024 Jul 26;10(15):e35200. doi: 10.1016/j.heliyon.2024.e35200. eCollection 2024 Aug 15.
5
Exploring the multifaceted role of obesity in breast cancer progression.探索肥胖在乳腺癌进展中的多方面作用。
Front Cell Dev Biol. 2024 Jul 8;12:1408844. doi: 10.3389/fcell.2024.1408844. eCollection 2024.
6
The relation between excess adiposity and breast cancer in women: Clinical implications and management.女性体内脂肪过多与乳腺癌的关系:临床意义及管理
Crit Rev Oncol Hematol. 2024 Jan;193:104213. doi: 10.1016/j.critrevonc.2023.104213. Epub 2023 Nov 24.
7
Stromal cells in the tumor microenvironment: accomplices of tumor progression?肿瘤微环境中的基质细胞:肿瘤进展的帮凶?
Cell Death Dis. 2023 Sep 4;14(9):587. doi: 10.1038/s41419-023-06110-6.
8
Understanding the mechanisms underlying obesity in remodeling the breast tumor immune microenvironment: from the perspective of inflammation.从炎症角度理解肥胖重塑乳腺肿瘤免疫微环境的机制
Cancer Biol Med. 2023 Mar 8;20(4):268-86. doi: 10.20892/j.issn.2095-3941.2022.0547.
9
Cancer-Associated Adipocytes and Breast Cancer: Intertwining in the Tumor Microenvironment and Challenges for Cancer Therapy.癌症相关脂肪细胞与乳腺癌:肿瘤微环境中的相互交织及癌症治疗面临的挑战
Cancers (Basel). 2023 Jan 24;15(3):726. doi: 10.3390/cancers15030726.
10
The Adipocyte-Macrophage Relationship in Cancer: A Potential Target for Antioxidant Therapy.癌症中脂肪细胞与巨噬细胞的关系:抗氧化治疗的潜在靶点
Antioxidants (Basel). 2023 Jan 4;12(1):126. doi: 10.3390/antiox12010126.
血清白细胞介素-8(IL-8)水平的变化反映并预测了抗 PD-1 治疗对黑色素瘤和非小细胞肺癌患者的疗效。
Ann Oncol. 2017 Aug 1;28(8):1988-1995. doi: 10.1093/annonc/mdx190.
4
Autocrine VEGF and IL-8 Promote Migration via Src/Vav2/Rac1/PAK1 Signaling in Human Umbilical Vein Endothelial Cells.自分泌血管内皮生长因子和白细胞介素-8通过Src/Vav2/Rac1/PAK1信号通路促进人脐静脉内皮细胞迁移。
Cell Physiol Biochem. 2017;41(4):1346-1359. doi: 10.1159/000465389. Epub 2017 Mar 9.
5
Estradiol Promotes Breast Cancer Cell Migration via Recruitment and Activation of Neutrophils.雌二醇通过招募和激活中性粒细胞促进乳腺癌细胞迁移。
Cancer Immunol Res. 2017 Mar;5(3):234-247. doi: 10.1158/2326-6066.CIR-16-0150. Epub 2017 Feb 3.
6
The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts.过表达 VEGF 的乳腺癌异种移植物中的血管生成分泌组。
Sci Rep. 2016 Dec 20;6:39460. doi: 10.1038/srep39460.
7
Supernatants of Adipocytes From Obese Versus Normal Weight Women and Breast Cancer Cells: In Vitro Impact on Angiogenesis.肥胖与正常体重女性脂肪细胞及乳腺癌细胞的上清液:对血管生成的体外影响
J Cell Physiol. 2017 Jul;232(7):1808-1816. doi: 10.1002/jcp.25701. Epub 2016 Dec 20.
8
Senescent Carcinoma-Associated Fibroblasts Upregulate IL8 to Enhance Prometastatic Phenotypes.衰老相关的癌细胞相关成纤维细胞上调白细胞介素 8 以增强促转移表型。
Mol Cancer Res. 2017 Jan;15(1):3-14. doi: 10.1158/1541-7786.MCR-16-0192. Epub 2016 Sep 27.
9
The Zebrafish Xenograft Platform: Evolution of a Novel Cancer Model and Preclinical Screening Tool.斑马鱼异种移植平台:一种新型癌症模型及临床前筛选工具的演变
Adv Exp Med Biol. 2016;916:289-314. doi: 10.1007/978-3-319-30654-4_13.
10
Expression of CCL2 is significantly different in five breast cancer genotypes and predicts patient outcome.CCL2在五种乳腺癌基因型中的表达存在显著差异,并可预测患者的预后。
Int J Clin Exp Med. 2015 Sep 15;8(9):15684-91. eCollection 2015.